This conference is a yearly event organised by the EFGCP Children Medicines Working Party in collaboration with DIA and Regulators to take stock of the progress achieved in the paediatric field after ten years of Paediatric Regulation

This year’s conference focuses on what could be done to optimise children’s access to new medicines.

“Access” can be broadly defined as:

• Inclusion of paediatric patients into clinical trials

• Health authority approval of a new medicine and

• Children’s access to a medicine that has been approved by regulators.

aPODD’s trustee Evgenia Mengou will be attending this conference.